Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Citius Oncology Inc (NASDAQ:CTOR), Fate Therapeutics Inc (NASDAQ:FATE), Whitehawk Therapeutics Inc (NASDAQ:WHWK) and Entera Bio Ltd (NASDAQ:ENTX).
Atossa Therapeutics has a consensus price target of $6.33.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $0.77 last updated December 12, 2025 at 7:59 PM EST.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.